Form4insider filings, from the source

Insider holders · CIK 0001346830

Tvardi Therapeutics, Inc. · TVRD

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
RMV VI, L.L.C.10% Owner—3,568,0573,568,057Apr 3, 2017 · 9:19 am EDTForm 4
RHO Ventures VI LP10% Owner—3,568,0573,568,057Apr 3, 2017 · 9:19 am EDTForm 4
Rho Capital Partners LLC10% Owner—3,568,0573,568,057Apr 3, 2017 · 9:19 am EDTForm 4
Mark Leschly10% Owner—3,568,0573,568,057Apr 3, 2017 · 9:19 am EDTForm 4
Habib Kairouz10% Owner—3,568,0573,568,057Apr 3, 2017 · 9:19 am EDTForm 4
Joshua Ruch10% Owner—3,568,0573,568,057Apr 3, 2017 · 9:19 am EDTForm 4
Martin VogelbaumDirector—3,068,0573,068,057Mar 18, 2016 · 7:43 pm EDTForm 4
Dean SlagelDirector—1,064,3381,064,338Jul 3, 2017 · 5:53 pm EDTForm 4
Derek T ChalmersPresident & CEO943,996—943,996Mar 5, 2019 · 4:53 pm ESTForm 4
Michael E LewisChief Scientific Advisor314,988—314,988Jan 27, 2016 · 5:10 pm ESTForm 4
Frederique Menzaghi Ph.D.Sr VP-Research & Development142,779—142,779Mar 4, 2019 · 5:49 pm ESTForm 4
Josef SchoellChief Financial Officer50,000—50,000Jul 28, 2017 · 4:53 pm EDTForm 4
Mani MohindruCFO & Chief Strategy Officer8,026—8,026Jan 2, 2019 · 5:54 pm ESTForm 4
Scott TerrillionSec'y; Chief Compliance & G.C.6,386—6,386Jan 2, 2019 · 5:56 pm ESTForm 4
Joseph William StaufferChief Medical Officer2,000—2,000Oct 19, 2018 · 4:34 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.